Bludigo Injection
Product Images NDC 25021-840

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bludigo (NDC 25021-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Blu00 0000 01)

Chemical structure diagram of indigotindisulfonate sodium, the active ingredient in Bludigo injection, illustrating its molecular arrangement with sulfonate groups attached to an indigo backbone.*

FDA Label Image

Package Label – Principal Display Panel – Ampule Label (Blu00 0000 02)

Bludigo Indigotindisulfonate Sodium Injection, USP 40 mg per 5 mL (8 mg per mL) intravenous single-dose ampule. The label states 'Intravenous Use Only' and indicates it is a 5 mL ampule. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in France. Includes batch and expiration barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.